Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Research Advances

Illustration of a microscope, beakers, and test tubes
Featured Article

Progress Now: Drug Approvals and Clinical Trial Updates

By MDA Staff | May 26, 2026
Detailed 3D illustration of a human heart with visible arteries and veins against a dark background.
Featured Article

New Cardiac Insights Show How Neuromuscular Diseases Affect the Heart

By Chris Anselmo | May 26, 2026
Adrian Krainer, PhD
Blog Post

Letter from the Editor: How New Higher-Dose Regimen for Spinraza Brings More Hope

By Mindy Henderson | March 30, 2026
Human brain anatomy with Neurons, brain cells, neural network Synaptic transmission , Synapses. 3d illustration
Blog Post

Rare Disease Day: Momentum in Neuromuscular Diseases is Building, but Progress Depends on Sustained Investment

By Brian Lin, PhD | February 27, 2026
Illustration of a microscope, lab beakers, and test tubes.
Featured Article

Progress Now: Research Updates and Breakthroughs

By MDA Staff | February 23, 2026
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | October 8, 2025
Blog Post

Quest Podcast: Precision Medicine: Mapping the Genetic Code for New Treatments

By MDA Staff | September 24, 2025
Blog Post

Behind the Drug: Nusinersen (Spinraza) for SMA

By Maggie Callahan | August 6, 2025
Woman in electric wheelchair waits for consultation with doctor in clinic waiting area. Nurse invites patient with disability on procedures. Medical staff and people in modern medical facility lobby.
Blog Post

Behind the Drug: Risdiplam (Evrysdi) for SMA

By Maggie Callahan | July 31, 2025
Male doctor giving a speech on a podium at a conference in front of an audience
Blog Post

MDA Conference Grants Support Resources to the Community

By MDA Staff | May 21, 2025
  • 1
  • 2
  • 3
  • …
  • 12
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1021 W Adams Street
2nd Floor, Suite 1073
Chicago, Illinois 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset